Insights

Phase 3 Focus Lixivaptan in Phase 3 for ADPKD indicates near-commercial potential. Target partnerships with specialty nephrology players or licensing deals to accelerate global access.

Small Team Outsourcing With 11-50 employees, Palladio relies on CROs and contractors. This creates sales opportunities for end-to-end clinical operations, regulatory support, and scalable manufacturing partnerships.

Strategic Financing A $20M Series B raised in 2020 signals investor appetite and potential for milestone-driven collaborations or co-development investments.

Orphan Kidney Focus Specialization in orphan kidney diseases opens doors with renal disease specialists, patient advocacy groups, and HEOR/payor partners to build value justifications.

Centessa Synergy As a Centessa company, Palladio may benefit from ecosystem partnerships and cross-portfolio opportunities; explore co-development or license deals within the Centessa network.

Palladio Biosciences, Inc., a Centessa company Tech Stack

Palladio Biosciences, Inc., a Centessa company uses 8 technology products and services including WP Rocket, Cloudflare, Twemoji, and more. Explore Palladio Biosciences, Inc., a Centessa company's tech stack below.

WP Rocket

Caching

Cloudflare

Content Management System

Twemoji

Font Scripts

Font Awesome

Font Scripts

Google Fonts API

Font Scripts

NextGEN Gallery

Photo Galleries

Yoast SEO

Search Engines

Plesk

Web Hosting

Palladio Biosciences, Inc., a Centessa company Email Formats	Example	Percentage
FLast@palladiobio.com	JDoe@palladiobio.com	73%
Last@palladiobio.com	Doe@palladiobio.com	27%

Palladio Biosciences, Inc., a Centessa company Email Formats

Example

Percentage

FLast@palladiobio.com

JDoe@palladiobio.com

73%

Last@palladiobio.com

Doe@palladiobio.com

27%

Frequently Asked Questions

Where is Palladio Biosciences, Inc., a Centessa company's headquarters located?

Palladio Biosciences, Inc., a Centessa company's main headquarters is located at 5 Walnut Grove Drive Suite 120 Horsham, Pennsylvania 19044 United States. The company has employees across 1 continents, including North America.

What is Palladio Biosciences, Inc., a Centessa company's official website and social media links?

Palladio Biosciences, Inc., a Centessa company's official website is palladiobio.com and has social profiles on LinkedIn.

What is Palladio Biosciences, Inc., a Centessa company's SIC code NAICS code?

Palladio Biosciences, Inc., a Centessa company's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Palladio Biosciences, Inc., a Centessa company have currently?

As of February 2026, Palladio Biosciences, Inc., a Centessa company has approximately 20 employees across 1 continents, including North America. Key team members include Chief Business Officer: L. H.Chief Financial Officer Head Of Qa: M. T.Vice President Clinical Operations, Palladio Biosciences: E. R.. Explore Palladio Biosciences, Inc., a Centessa company's employee directory with LeadIQ.

What industry does Palladio Biosciences, Inc., a Centessa company belong to?

Palladio Biosciences, Inc., a Centessa company operates in the Biotechnology Research industry.

What technology does Palladio Biosciences, Inc., a Centessa company use?

Palladio Biosciences, Inc., a Centessa company's tech stack includes WP RocketCloudflareTwemojiFont AwesomeGoogle Fonts APINextGEN GalleryYoast SEOPlesk.

What is Palladio Biosciences, Inc., a Centessa company's email format?

Palladio Biosciences, Inc., a Centessa company's email format typically follows the pattern of FLast@palladiobio.com. Find more Palladio Biosciences, Inc., a Centessa company email formats with LeadIQ.

How much funding has Palladio Biosciences, Inc., a Centessa company raised to date?

As of February 2026, Palladio Biosciences, Inc., a Centessa company has raised $20M in funding. The last funding round occurred on Sep 25, 2020 for $20M.

When was Palladio Biosciences, Inc., a Centessa company founded?

Palladio Biosciences, Inc., a Centessa company was founded in 2015.

Palladio Biosciences, Inc., a Centessa company

Q: What is Palladio Biosciences, Inc., a Centessa company's NAICS code?

Palladio Biosciences, Inc., a Centessa company's NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchPennsylvania, United States11-50 Employees

Palladio Biosciences, Inc. operates in the biotechnology research space as a clinical-stage company focused on kidney-related orphan diseases. Its lead product, lixivaptan, is in Phase 3 clinical development for autosomal polycystic kidney disease (ADPKD), a chronic, progressive condition characterized by fluid-filled cysts in the kidneys and significant burden on patients and families. The company aims to provide a safe, chronic-treatment option that could slow the progression of PKD, addressing an area with no current cure. Based in Horsham, Pennsylvania, Palladio is part of a broader ecosystem of biopharmaceutical firms developing treatments for niche kidney diseases and operates under the umbrella of Centessa. The organization has positioned itself as a clinical-stage company targeting orphan kidney diseases, with a focus on translating its research into therapeutic candidates for patients in need.

Insights

Similar companies to Palladio Biosciences, Inc., a Centessa company

Roche

sanofi

Vertex Pharmaceuticals

Pfizer

AstraZeneca

Genentech

Biogen

Gilead Sciences

Novartis Institutes for BioMedical Research

Amgen